Gut hormone GIP may hold key to stronger bones

NCT ID NCT06790225

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how a natural gut hormone called GIP affects bone remodeling. Researchers will give GIP to 12 healthy adults in two ways—intermittent (8 hours daily) and continuous (24 hours daily)—to see which better reduces bone breakdown. Blood samples and bone marrow tests will measure changes in bone cell activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Glucose-dependent Insulinotropic Polypeptide (GIP)
What this could lead to
If successful, this could clarify how GIP affects bone health, potentially guiding future treatments for bone diseases in people with diabetes or obesity.
What could go wrong
This is a very small, early-stage study in healthy volunteers, not patients. Results may not apply to people with bone disease or diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE DISEASE, METABOLIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University hospital of Southern Denmark

    RECRUITING

    Esbjerg, 6700, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.